Anne E. Fung

An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration

Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld et al. · American Journal of Ophthalmology · 2007 · 966 citations

Ocular Disease, Vitreous Body, Optical Coherence Tomography-guided +6

A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study

Geeta A. Lalwani, Philip J. Rosenfeld, Anne E. Fung et al. · American Journal of Ophthalmology · 2009 · 882 citations

Ocular Disease, Vitreous Body, Ophthalmology +8

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide

Anne E. Fung, Philip J. Rosenfeld, Elias Reichel · British Journal of Ophthalmology · 2006 · 534 citations · Full text

Ocular Disease, Drug-related Adverse Events, Pharmacotherapy +17

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

Philip J. Rosenfeld, Anne E. Fung, Carmen A. Puliafito · PubMed · 2005 · 467 citations

Macular Edema, Radiology, Bevacizumab Injection +9

Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Macular Edema From Central Retinal Vein Occlusion

Philip J. Rosenfeld, Anne E. Fung, Carmen A. Puliafito · Ophthalmic surgery, lasers & imaging retina · 2005 · 339 citations

Macular Edema, Vitreous Body, Bevacizumab Injection +11